This Page is for the Historic Record: only basic formatting has been done
Please click here to go to an overview of APTN's past Forum and Conference programme
(UK-Japan Life Sciences Meeting)
(This Conference was linked to the 14th UK-Japan High Technology Industry Forum
Tuesday 13 July 1999, Stevenage
Sponsored by
GlaxoWellcome
SmithKline Beecham
In Association with
Asia-Pacific Technology Network
Ballantyne Ross
Euro Japan Marketing
MIDAS
Technomark Consulting
BACKGROUND
Both Japan and the UK have identified developments in neuroscience research as key to meeting important needs of society in the future. Neurological disease is increasingly influencing the quality of life, particularly of our older citizens and their carers, as advances in medical knowledge bring previously fatal conditions under control.
In the UK, the Health & Life Sciences Panel of Foresight has called for new national initiatives in neuroscience research, including increased investment in medical imaging facilities. While in Japan, support for the Institute of Brain Science at RIKEN has received political backing at the highest level. Japan is committed to significant expenditure in basic research on three interrelated themes: understanding the brain, protecting the brain and building the brain.
Building on the success of our bilateral meeting on Bioinformatics at Kanagawa Science Park in October 1998, this year’s meeting will focus on the leading edge developments in medical imaging which are seen to be key to progress in basic and clinical research in brain research. There will be particular emphasis in the scientific programme on the competing techniques of positron emission tomography (PET) and functional magnetic resonance imaging (fMRI).
Also included will be sessions on developments, based on new approaches such as optical imaging, as well as on more established techniques now finding wider application, such as the use of gamma scintigraphy to improve the design clinical trials of drugs administered through the lungs. Modern imaging techniques rely heavily on developments in data acquisition,
manipulation, interpretation and display, which will also be addressed.
PROGRAMME
09.00 Registration and coffee
09.30 Welcome and Opening Remarks
Conference Chairman: Professor Sir Colin Dollery, Senior
Consultant, SmithKline Beecham
09.45 SESSION 1
Chair: Professor David Delpy, Hamamatsu Professor of
Medical Photonics, University College London
09.50 Professor Paul Matthews, Director, Centre for Functional Magnetic Imaging of the Brain, John Radcliffe Hospital, Oxford Functional Magnetic Resonance Imaging: Clinical
Applications and Potential
10.20 Dr Hideo Tsukada, Senior Researcher, Hamamatsu PET Centre, Central Research Laboratory, Hamamatsu Photonics KK Application of Animal PET for Drug Development
10.50 Question & Answer
11.00 Coffee
11.30 SESSION 2
Chair: Dr Julie Barnes, Head of Neuroscience, Glaxo
Wellcome plc
11.35 Professor Stephen Jackson, Clinical Age Research Unit, Department of Gerentology, King's College School of Medicine, London Study of Alzheimer's Disease using Functional Magnetic Resonance Imaging
12.05 Professor Laurie Hall, Director, Herchel Smith Laboratory, Cambridge Measuring the Damaged Brain: from Animal Models to Clinical Practice
12.35 Question & Answer
12.45 Lunch
14.00 SESSION 3
Chair: Dr Julie Barnes, Head of Neuroscience, Glaxo
Wellcome plc
14.05 Professor Robert Turner, Wellcome Principal Research Fellow, Wellcome Department of Cognitive Neurology, Institute of Neurology, London PET & fMRI Developments at the Institute of Neurology
14.35 Dr Michinori Ichikawa, Brain-operative Device Lab, Brainway Group, Brain Science Institute, RIKEN Advanced Optical / Electrical Imaging Technology for
Real~Time Monitoring of Neural Activities in the Brain
15.05 Question & Answer
15.15 Tea
15.45 SESSION 4
Chair: Professor David Delpy, Hamamatsu Professor of
Medical Photonics, University College London
15.50 Professor Chris Taylor, Department of Medical Biophysics, University of Manchester Developments in Image Data Capture and Analysis
16.20 Dr Stephen Newman, Chief Scientist, Pharmaceutical Profiles Ltd Imaging Techniques to Evaluate Lung Deposition
16.50 Question & Answer
17.00 Conference Summary and Final Discussion
Conference Chairman: Professor Sir Colin Dollery, Senior
Consultant, SmithKline Beecham
17.30 Departure by Coach to Plymouth for participants attending the 14th UK~Japan High Technology Industry Forum
This programme may be subject to minor changes
LOCATION
The Lecture Theatre
Glaxo Wellcome Research and Development
Medicines Research Centre
Gunnels Wood Road
Stevenage, Herts SG1 2NY